in collaboration with:
In an effort to showcase the latest technologies driving the production of cell therapies, the Cell Therapy Group and Informa Life Sciences are proud to announce the introduction of the "Technology Showcase" session and award to be held in conjunction with Informa's Cell Therapy Manufacturing conference to be held 30 November to 1 December 2011 in Brussels Belgium.
Having held the same conference last year in London, Informa is committed to building on the success of last year's event by continuing to create a meaningful European forum for the issues related to the clinical and particularly commercial-scale production of cell-based therapies.
The Technology Showcase session, taking place on the main agenda, will feature 6 x 10 minute presentations from innovative companies developing cutting-edge technologies in the field of cell therapy manufacturing, and is particularly relevant to SME and academic groups with limited marketing resources.
All presentations will be reviewed by the Scientific Advisory Board with the winner announced at the end of the session. Exposure on BioProcess International's website is also included.
Technologies we'd like to promote include:
- Manufacturing systems including bioreactor technologies
- Cell harvest/collection technologies
- Cell storage/logistics technologies
- Clinical cell delivery and/or other point-of-care technologies
- Automation technologies
- Cell separation system
- Cell process devices
- Innovative reagents, scaffolds, matrices, and other “ancillary” tools
- Technologies to close currently open systems
- Suspension-based production systems
- Disposable technologies
How to apply:
To apply to present companies must submit an abstract (<300 words) to daniel.barry@informa.com and lbuckler@celltherapygroup.com outlining the product or service to be presented and why it is a critical technology related to cell therapy manufacturing.
The deadline for applications is SEPTEMBER 15 2011 - Priority given to early submissions
The cost of taking part in the Technology Showcase is £2,700 which includes the following benefits:
- 1 x 2-day conference pass (normal price £1,599)
- 10-minute podium presentation within main conference room
- 1 poster display in the Exhibition Hall
- Marketing - company logo displayed on website and event guide
- Exposure in BPI Magazine
Terms and conditions:
To be eligible the product or service to be presented must be:
- On the market for no less than 2 years or expected to be on the market no later than Q4 2012
- Appropriate for, applicable to, and compliant with clinical-grade manufacturing requirements (technologies only available for research use will not be considered)
Plus...
- The company must have no more than 15 employees
- The company has been running for no more than 5 years, and
- The company generates annual revenue of no more than $5m
For further information please contact: daniel.barry@informa.com or lbuckler@celltherapygroup.com
- Stem cells for a Webby! [Last Updated On: August 18th, 2024] [Originally Added On: April 28th, 2010]
- Latest Cell Therapy Approval by FDA. Dendreon's Provenge. [Last Updated On: August 18th, 2024] [Originally Added On: April 30th, 2010]
- Latest Cell Therapy Approval by FDA. Dendreon's Provenge. [Last Updated On: August 18th, 2024] [Originally Added On: April 30th, 2010]
- Google to Invest in Regenerative Medicine [Last Updated On: August 18th, 2024] [Originally Added On: May 5th, 2010]
- Biotech tax credit appears perfectly designed for cell therapy companies to recoup research dollars spent in 2009-10 [Last Updated On: August 18th, 2024] [Originally Added On: May 22nd, 2010]
- The changing face of PR and why it matters to regenmed [Last Updated On: August 18th, 2024] [Originally Added On: June 12th, 2010]
- FDA files injunction again Regenerative Sciences citing Regenexx violates regulations [Last Updated On: August 18th, 2024] [Originally Added On: August 12th, 2010]
- Careers in cell therapy & regenerative medicine [Last Updated On: August 18th, 2024] [Originally Added On: October 11th, 2010]
- Careers in cell therapy & regenerative medicine [Last Updated On: August 18th, 2024] [Originally Added On: October 11th, 2010]
- The LinkedIn Cell Therapy Industry Group - 1,000 members strong [Last Updated On: August 18th, 2024] [Originally Added On: February 14th, 2011]
- Cell Therapies: Commercializing a New Class of Biopharmaceuticals [Last Updated On: August 18th, 2024] [Originally Added On: February 14th, 2011]
- In vivo cell trafficking just took a leap forward [Last Updated On: August 18th, 2024] [Originally Added On: July 3rd, 2011]
- Cell Therapy's Got Talent Technology Showcase - A Call for Cell Therapy Manufacturing Technology Presentations [Last Updated On: August 18th, 2024] [Originally Added On: July 10th, 2011]
- Clinical trial costs [Last Updated On: August 18th, 2024] [Originally Added On: July 31st, 2011]
- Good Data? $100. Good Product Development? $100. Good Commercialization Strategy? Priceless. [Last Updated On: August 18th, 2024] [Originally Added On: August 14th, 2011]
- Potential far-reaching implications of the ongoing fight over point-of-care autologous cell therapy [Last Updated On: August 18th, 2024] [Originally Added On: September 18th, 2011]
- Commercial-stage Cell Therapy Companies and Products [Last Updated On: August 18th, 2024] [Originally Added On: September 18th, 2011]
- Cell Therapy & Regenerative Medicine Domains Available [Last Updated On: August 18th, 2024] [Originally Added On: September 25th, 2011]
- Cell Therapy & Regenerative Medicine Domains Available [Last Updated On: August 18th, 2024] [Originally Added On: September 25th, 2011]
- Commercializing Cell-based Regenerative Medicines [Last Updated On: August 18th, 2024] [Originally Added On: November 13th, 2011]
- Sabrina Cohen Foundation Thanks Stem Cell Researchers [Last Updated On: August 18th, 2024] [Originally Added On: November 27th, 2011]
- Active phase III or II/III cell therapy trials [Last Updated On: August 18th, 2024] [Originally Added On: December 11th, 2011]
- Recently approved cell therapy products [Last Updated On: August 18th, 2024] [Originally Added On: December 18th, 2011]
- Inactive and recently failed or terminated phase III or II/III cell therapy trials [Last Updated On: August 18th, 2024] [Originally Added On: December 18th, 2011]
- 2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned? [Last Updated On: August 18th, 2024] [Originally Added On: January 1st, 2012]
- Predicting the Success of the Late-Stage Cell-Based Cancer Immunotherapy Pipeline? [Last Updated On: August 18th, 2024] [Originally Added On: March 11th, 2012]
- Another > $100M month for companies in the cell therapy space [Last Updated On: August 18th, 2024] [Originally Added On: May 6th, 2012]
- Another > $100M month for companies in the cell therapy space [Last Updated On: August 18th, 2024] [Originally Added On: May 6th, 2012]
- Cell-based Cancer Immunotherapies. Some metrics.. [Last Updated On: August 18th, 2024] [Originally Added On: May 20th, 2012]
- Industry-sponsored cardiovascular cell therapies. Some metrics. [Last Updated On: August 18th, 2024] [Originally Added On: May 27th, 2012]
- Bioreactor Design and Bioprocess Controls for Industrialized Cell Processing [Last Updated On: August 18th, 2024] [Originally Added On: June 17th, 2012]
- FDA 1. RSI 0. Regenerative Sciences (Regenexx) vs FDA (2012) [Last Updated On: August 18th, 2024] [Originally Added On: July 29th, 2012]
- Is the cell therapy sector outperforming the major indices? [Last Updated On: August 18th, 2024] [Originally Added On: August 12th, 2012]
- Are some cell counts too good to be true? Why some companies' product data may mislead. [Last Updated On: August 18th, 2024] [Originally Added On: September 2nd, 2012]
- Are some cell counts too good to be true? Why some companies' product data may mislead. [Last Updated On: August 18th, 2024] [Originally Added On: September 2nd, 2012]
- Two lessons I learned this week. [Last Updated On: August 18th, 2024] [Originally Added On: September 16th, 2012]
- The cost of clinical trial data bias/loss, FDA's new job and the need for bold leadership. [Last Updated On: August 18th, 2024] [Originally Added On: September 30th, 2012]
- Anticipated short-term cell therapy industry clinical milestones [Last Updated On: August 18th, 2024] [Originally Added On: September 30th, 2012]
- The cost of clinical trial data bias/loss, FDA's new job and the need for bold leadership. [Last Updated On: August 18th, 2024] [Originally Added On: September 30th, 2012]
- Cell therapy portfolio outperforms major indices year-to-date [Last Updated On: August 18th, 2024] [Originally Added On: October 14th, 2012]
- CIRM addresses some tough questions. Is it all just glass towers and basic research? [Last Updated On: August 18th, 2024] [Originally Added On: October 21st, 2012]
- GEN's "Cellular Therapy Wave Finally Cresting". An overview and data set. [Last Updated On: August 18th, 2024] [Originally Added On: November 4th, 2012]
- GEN's "Cellular Therapy Wave Finally Cresting". An overview and data set. [Last Updated On: August 18th, 2024] [Originally Added On: November 4th, 2012]
- Cell Therapy Industry Group Welcomes its 4,000th member [Last Updated On: August 18th, 2024] [Originally Added On: November 11th, 2012]
- Six steps to fighting non-compliant cell therapy treatments. --- The stuff of grey shades, spades, ivory towers and (ahem) balls. [Last Updated On: August 18th, 2024] [Originally Added On: December 2nd, 2012]
- A proposed 6-step platform for the cell therapy industry to consider in combating non-compliant cell therapy treatments [Last Updated On: August 18th, 2024] [Originally Added On: December 16th, 2012]
- The ROI on pant-wearing and other social media tips [Last Updated On: August 18th, 2024] [Originally Added On: December 16th, 2012]
- The Accuracy of Adipose Stem Cell Doses [Last Updated On: August 18th, 2024] [Originally Added On: December 23rd, 2012]
- Cell Therapy Blog welcomes 2013 [Last Updated On: August 18th, 2024] [Originally Added On: January 6th, 2013]
- 2013 Annual Regenerative Medicine Industry Report [Last Updated On: August 18th, 2024] [Originally Added On: April 21st, 2013]
- Commercialization of Regenerative Medicine: Learning from Spin-Outs [Last Updated On: August 18th, 2024] [Originally Added On: April 28th, 2013]